Inkjet printers 'empower' pharmaceutical packaging, consumers know the roots of the code scanning

When QR codes were rampant around the world, drug manufacturers put forward a false impression: Whether a QR code can be installed on the drug packaging, patients only need to scan it to get all the information about the drug. In this sense, it is possible to reduce cases of wrong medication and counterfeit drugs. At that time, the industry believed that installing a QR code only requires filing and ensuring that the scanned information is true and compliant. However, there are also concerns in the industry that if the QR code is skewed during printing or wrinkled during transportation, it will be difficult for patients. Read the information, which will have an impact on the patient's normal medication. In recent years, in order to promote the construction of a traceability system in the pharmaceutical industry and ensure drug safety, drug packaging has begun to take the route of technology, standardization, and traceability. The upgrade of pharmaceutical inkjet printers and other equipment has made many contributions to the traceability of pharmaceuticals, from the need to print labels and then label them to the direct printing of labels on pharmaceutical packaging in one step, which saves costs and can easily label pharmaceuticals. Data information is obtained so that it can be entered into the medical big data system for management. Some pharmaceutical companies said that companies can now label or generate codes on products through self-adhesive labeling, spray code, etc. according to their own needs. After finishing the code or generating codes, the QR code will become the product's The identification code realizes one item and one code to ensure the traceability of medicines. Pharmaceutical manufacturers can have a comprehensive understanding of downstream sales, and at the same time prevent the occurrence of fleeing goods, ensure the safety of drugs, and protect the rights and interests of consumers. In order to ensure the traceability of drugs, the “Opinions of the General Administration on Promoting Food and Drug Manufacturers to Improve the Traceability System” issued by the former Food and Drug Administration in September 2016 emphasized that food and drug manufacturers should undertake the food and drug traceability system. The main responsibility of the construction is to realize the source of the products produced and operated and the whereabouts of the products can be traced. However, due to the lack of traceability system standards and specific rules, it has not yet played a powerful role in food and drug operators. On August 24, 2018, the National Medical Products Administration issued the 'Guiding Opinions on the Establishment of Drug Information Traceability System' and attached two standard documents to solicit public opinions. The opinion emphasizes that the construction of the drug information traceability system should be based on the implementation of the main responsibility of the enterprise, with the realization of one item, one code, and the same code as the direction, to build a drug traceability system for the entire variety and the whole process. The issuance of the guidance has caused the industry to once again discuss the construction of the drug information traceability system. In order to promote the establishment of a drug information traceability system, the State Food and Drug Administration also issued and implemented two informatization 'Guidelines for the Construction of Drug Information Traceability System' (hereinafter referred to as 'Guidelines') and 'Drug Traceability Code Coding Requirements' in May this year. standard. The 'Guidelines' pointed out that the drug information traceability system should include a drug traceability system, a drug traceability collaborative service platform, and a drug traceability supervision system. At the same time, it should also include the traceability information of the whole process of drug production, circulation and use, and have the functions of collecting, storing and sharing traceability information. It can be divided into two categories: enterprise self-built traceability system and traceability system provided by third-party organizations. . In addition, it is emphasized that the data exchange between the drug traceability system, the collaborative platform, and the drug traceability supervision system should comply with the relevant technical standards for data exchange established by the State Food and Drug Administration. In general, the drug traceability system is becoming more and more standardized and standardized, which is conducive to better constraining the business behavior of drug manufacturers, ensuring that the entire process of drug production, circulation and use can be traced, protecting the rights and interests of consumers, and for labeling. For printers and inkjet printer companies, there is also a lot of room for development in the future.